(EMAILWIRE.COM, December 07, 2018 ) According to the new market research report "Amniocentesis Needle Market by Type (Smaller Than 100 mm, 100 - 150 mm, Larger Than 150 mm), Procedure (Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion), End User (Hospitals, Diagnostic Centers, Clinics) - Global Forecast to 2022", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

Don’t miss out on business opportunities in Amniocentesis Needle Market.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=18541768

The amniocentesis needles market is expected to reach USD 172.8 million by 2022 from USD 146.4 million in 2016 at a CAGR of 2.8%.
The base year for this study is 2016 and the forecast period is 2017–2022. 100–150 mm needles are the most commonly used amniocentesis needles and are expected to account for the largest share of the global market in 2017. The large share of this segment can be attributed to the fact that these needles are suitable for most patients on account of their optimal length.

Use of amniocentesis needles in amniocentesis procedures drives the global 100–150 mm needles market
This type of needle is suitable for use in females with a normal body-mass index (BMI) of 18.50–24.99 kg/m2. There is an increase in the proportion of women who are overweight, this proportion will still be lesser than the proportion of women with normal BMI. This is one of the major factors responsible for the large share of 100–150 mm needles in the amniocentesis needles market. Amniocentesis procedure is the most commonly recommended invasive prenatal diagnostic test to detect chromosomal disorders, infections, or birth defects. In spite of a small proportion of risks associated with this procedure, amniocentesis is carried out to diagnose the abnormalities in the developing fetus. These are the major factors responsible for the large share of this procedure segment in the amniocentesis needles market.

Browse and in-depth TOC on "Amniocentesis Needle Market"
74 – Tables
34 - Figures
132 - Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/amniocentesis-needle-market-18541768.html

The following are the major objectives of the study:

• To define, describe, segment, and forecast the amniocentesis needles market on the basis of type, procedure, end user, and region
• To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)
• To identify the micromarkets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market
• To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To profile the key players and comprehensively analyze their market position and core competencies in terms of market developments and growth strategies
• To track and analyze competitive developments such as partnerships, agreements, collaborations, and joint ventures; mergers and acquisitions; product launches; and research and development activities in the amniocentesis needles market

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=18541768

Key Players:
The key players in the amniocentesis needles market include Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), Cook Medical (US), Laboratoire CCD (France), Biopsybell (Italy), RI.MOS. (Italy), TSUNAMI MEDICAL (Italy), and Rocket Medical (UK).

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting